Elbasvir/Grazoprevir Experience - A New Glance at HCV Treatment: Case Report
Journal Title: Viral Hepatitis Journal - Year 2017, Vol 23, Issue 1
Abstract
Hepatitis C is a viral disease having a worldwide importance and posing a risk for liver complications. With the new treatment options, it is easy to manage with higher rates of success. Among them, one of the most recent one is elbasvir/grazoprevir option. This study presents the results of two treatment-naive patients treated with elbasvir/grazoprevir. The first case was a male non-cirrhotic patient and the second one was a female who suffered from compensated hepatic cirrhosis. Both patients received elbasvir/grazoprevir 50/100 mg in a single tablet for 12 weeks. Persistent viral response was achieved in both patients and no side effect was observed during the treatment. Elbasvir/grazoprevir combination, one of the recent treatments, was considered effective and tolerable.
Authors and Affiliations
Mustafa Kemal ÇELEN, İrem AKDEMİR, Recep TEKİN, Kadim BAYAN, Celal AYAZ
Keywords
Related Articles
- EP ID EP228501
- DOI 10.4274/vhd.10337
- Views 46
- Downloads 0
Human Pegivirus (GB Virus Type C) and Its Relationship with HIV
Editorial
A Review of Hepatitis C in the General Population in Pakistan
To perform a systematic review of the recent scientific literature on hepatitis C infection (2010-2016) for epidemiology, genotypes, co-infection, risk factors and management regime in Pakistan. Present integrated, analy...
Elbasvir/Grazoprevir Experience - A New Glance at HCV Treatment: Case Report
Hepatitis C is a viral disease having a worldwide importance and posing a risk for liver complications. With the new treatment options, it is easy to manage with higher rates of success. Among them, one of the most recen...
Evaluation of Chronic Hepatitis C Patients from Different Aspects Before the Use of Direct Acting Antivirals
Objective: Chronic hepatitis C (CHC) virus infection is one of the leading causes of chronic liver disease in all over the world. The prevalence of CHC is almost 0.5-1% in Turkey. Until recently, pegylated-interferon (PE...
Percutaneous Liver Needle Biopsy Methods Can Be Safe and Effective in Patients with Viral Hepatitis
Objectives: The aims of this study were to evaluate the biopsy methods used in terms of safety, and effectiveness as well as incidence, and severity of complications. Materials and Methods: This study was conducted as a...